Green Shoots Lead Markets Higher

April 17, 2020

Optimism for a flattening COVID-19 curve in the U.S. and high hopes for Gilead’s experimental drug treatment for COVID-19 pushed the S&P 500 to a 3.04% weekly gain. The move comes on the heals of last week’s 12.10% rise, the index’s best one-week performance since 1974. The positive developments sparked investor optimism that the country would soon be able to re-open and get back to business. On the economic front, the data remained nothing short of dismal with retail sales plunging to a record low and another 5.245 million people applying for unemployment benefits. We also got our first read of global economic growth from China, who entered lockdown a month prior to the rest of the world. Not surprisingly, China’s Q1 2020 GDP shrank dramatically, but less than anticipated.

Shopping in the Times of Coronavirus

The run on toilet paper, bleach, and face masks were not enough to blunt March’s retail sales figures. Retail sales fell 8.70%, their biggest decline since the government began tracking the series in 1992. Defensive sectors did best as Americans hunkered down. Food and beverage sales rose 25.60%, general merchandise sales were up 6.40%, and health and personal items registered a 4.30% rise. Despite these strong sales figures, a 25.6% decline in autos, a 26.5% drop in restaurants, and a 50% decline in clothing sales served to drag down overall results. In the short-term, we do not expect to see much of a retail sales bounce as consumers remain cautious to spend amidst continued layoffs. For the week ending April 11th, an additional 5.245 million people applied for unemployment benefits, bringing the total number of claims to just over 22 million. For context, both the 1990-1991 and 2001 recessions saw total, initial jobless claims of approximately 15 million over a period of 36 weeks. The 2007-2009 recession resulted in approximately 37 million claims over a period of 79 weeks, which thus far we’ve managed to capture nearly 60% of in a mere four weeks.

COVID-19 Demand Shock Hits China GDP

Serving as a proxy for things to come for the rest of the global economy, China released its Q1 2020 GDP figures. For the quarter, the country saw a 6.80% drop in economic output as Beijing implemented large-scale shutdowns and quarantines in order to contain the spread of coronavirus. The drop was the first quarterly decline since at least 1992 when official quarterly records began. Digging into the reports, the numbers were ugly. Industrial production fell 8.40%, fixed-asset investment fell 16.1%, and retail sales fell a staggering 19%. Having been ground zero for the outbreak, China Q1 results were more heavily impacted than what we might expect elsewhere, and as bad as the numbers were, they were better than expected. China is now emerging from its lockdown and their economy is beginning to restart, which thus far appears to be working without a significant resurgence of the disease. On Thursday, China reported only 42 new cases, and all but four cases were imported. Things are still far from normal in China as social distancing measures remain in place and business activity is lethargic, particularly for exporters who have seen a sharp drop in global demand as the epicenter of the virus has shifted to the U.S. and Europe.

Markets have enjoyed a remarkable rally over the past two weeks believing they are seeing the initial green shoots of a recovery. From the beginning, we’ve structured our view for a recovery on two items. The first was to successfully solve the underlying health problem. If you stop or contain COVID-19 then, and only then, are you in a position to deal with the true economic damage. The stay-at-home orders for much of the nation seem to be having a positive effect on flattening the curve, reducing the number of deaths, and preventing a collapse of our healthcare system. Various treatments are showing promise in combating the disease, and there are hopes that a vaccine could be distributed in limited amounts by the fall. The worst-case scenarios now seem to be all but off the table, and there is a strong bias towards better than expected outcomes on the healthcare front now baked into the market. That seems a reasonable position justifying a sizeable bounce off March’s bottom, and the market is now focused on repairing the economic fallout and on earnings normalization. With the market now just 15% below its all-time high in February, the concern has to be whether this is all too fast, too quick. Aside from a miracle cure, the past three weeks could not have provided a better cadence of positive development for a market that was previously in turmoil. There has been a strong monetary response, fiscal response, and health response to the point where markets are now being valued in anticipation of where they believe things will be in September. That’s a long way from here, and while we are bullish, we also try to be realistic. There is a lot that still needs to happen to get this economy back to work, and it’s hard to imagine the market just going sideways from here simply waiting for Q3 earnings. A vaccine or treatment changes the entire calculus in what we are saying, but absent that, a continuation of the rally too much higher from here would border on irrational in our minds. Q1 and Q2’s earnings are still ahead. There is a ton of debt workout and negotiations that will need to take place, and it is going to take time to know what impact it will have on both Main Street and Wall Street. Then, there is the issue of jobs and — longer term — interest rates and taxation policy. It’s not that we don’t think we’re seeing definitive signs of green shoots. We are. It is just that we believe that it will take some time before it all bears fruit again.

The Week Ahead

Earnings season continues with reports from tech giants Intel and Texas Instruments. We’ll also check in on durable goods orders and the housing market.

We’re Here to Serve You

We hope all of our clients and friends are remaining healthy and safe. We understand these can be challenging times for so many individuals, families, and businesses given the disruptions to our daily lives and the personal, professional, and financial impact of the current pandemic. Your well-being is important to us, and we would love to hear how you are managing the “new normal” and how your businesses may be responding and adapting to these unprecedented circumstances.

We want to assure our clients that our business operations are open, and our team is continuing to provide the highest level of service and support. Our advisors remain available to help you successfully navigate challenging financial situations and markets, just as we have done during other periods of market turbulence and uncertainty.

Due to the pandemic, Probity Advisors, Inc.’s quarterly statements will be provided electronically through our website. Financial account statements serve several important purposes — confirming your account information, providing a helpful, high-level picture of your account performance from the end point of the previous statement, and listing the total value of your account(s) along with a summary of your holdings. Statements will be posted to our secure, online client portal in the coming weeks. We will be emailing our clients once the statements are available online. If you do not currently have access to our portal, please call our office so we can assist you.

Our team of analysts continues to share their insights on the news and events affecting investors. For our current perspectives on the markets and economy, we encourage you to read our weekly market commentary that is shared in this email every Friday as well as posted on our website here and on Facebook, LinkedIn, and Twitter.

As we continue to experience uncertainty and concern about the pandemic’s impact on our personal lives and our livelihoods, we are here to provide the support and guidance you need to make well-informed decisions. Thank you for your trust. We wish you and yours health and safety during this time.



Important Disclosure: The information contained in this presentation is for informational purposes only. The content may contain statements or opinions related to financial matters but is not intended to constitute individualized investment advice as contemplated by the Investment Advisors Act of 1940, unless a written advisory agreement has been executed with the recipient. This information should not be regarded as an offer to sell or as a solicitation of an offer to buy any securities, futures, options, loans, investment products, or other financial products or services. The information contained in this presentation is based on data gathered from a variety of sources which we believe to be reliable. It is not guaranteed as to its accuracy, does not purport to be complete, and is not intended to be the sole basis for any investment decisions. All references made to investment or portfolio performance are based on historical data. Past performance may or may not accurately reflect future realized performance. Securities discussed in this report are not FDIC Insured, may lose value, and do not constitute a bank guarantee. Investors should carefully consider their personal financial picture, in consultation with their investment advisor, prior to engaging in any investment action discussed in this report. This report may be used in one on one discussions between clients (or potential clients) and their investment advisor representative, but it is not intended for third-party or unauthorized redistribution. The research and opinions expressed herein are time sensitive in nature and may change without additional notice.